Bluebook
Pharma Services: Drug Development BlueBook December 2024
2024 - December: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Insite Clinical Research was acquired by Adams Clinical
- Kester Capital announced its acquisition of Emas Pharma
- Databricks closed a $10,175MM Series A Financing, led by Insight Venture, Wellington Management, and GIC